4.4 Review

cGMP signalling in cardiomyocyte microdomains

Journal

BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 47, Issue -, Pages 1327-1339

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BST20190225

Keywords

-

Funding

  1. Deutsche Forschungsgemeinschaft
  2. Gertraud und Heinz-Rose Stiftung
  3. European Research Area Network on Cardiovascular Diseases (ERA-CVD)

Ask authors/readers for more resources

3',5'-Cyclic guanosine monophosphate (cGMP) is one of the major second messengers critically involved in the regulation of cardiac electrophysiology, hypertrophy, and contractility. Recent molecular and cellular studies have significantly advanced our understanding of the cGMP signalling cascade, its local microdomain-specific regulation and its role in protecting the heart from pathological stress. Here, we summarise recent findings on cardiac cGMP microdomain regulation and discuss their potential clinical significance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available